To investigate the impact of the route of inoculation on the application of MCMV-based vaccine vectors for vaccine-elicited immunity against cancer, we compared the magnitude and kinetics of the antigen-specific CD8+ T cell response in the blood upon IP, IN and SC inoculation. The gene discussed is CD8A; the disease is cancer.